Congratulations to the graduating class of BSBE, IIT Kanpur! 🎓
Celebrating your hard work, achievements, and the exciting journey ahead. Wishing you continued success and impact in science and beyond!
#Convocation2026#IITKanpur#BSBE#FutureLeaders
The weight-loss-independent hepatoprotective benefits of semaglutide are orchestrated by intrahepatic sinusoidal endothelial GLP-1 receptors: Cell Metabolism https://t.co/Hyos5MgMNS
While I’m a big fan of new technologies that help us study human biology…there’s still no replacement for animal research! I wrote an article outlining this in @GENbio
https://t.co/CGXeaMs7Fa
Hemophilia causes bleeding into joint cavities resulting in Hemophilic arthropathy (HA). Prof. Jayandharan Rao & team show administration of miR125a-5p decreases HA-linked inflammation & cartilage-degradation.
https://t.co/lmC0Kh9nAd
@BSBEIITK1@MehtaFF#GeneTherapy
BSBE is happy to announce collaborative agreement between @LaurusLabs & @IITKanpur led by our colleague Jayandharan G. Rao to jointly develop #GeneTherapy platform as #madeinindia initiative to provide affordable treatment for Retinal Degeneration, Hemophilia, Muscular Dystrophy
The recent collaboration between @IITKanpur and @LaurusLabs on #GeneTherapy is focused on developing affordable and high-quality genetic medicine ‘#MadeinIndia’ for the world. Initially, this will be for Leber congenital Amaurosis, a type of hereditary eye disease, Hemophilia, and muscular dystrophy. The focus is also on establishing all aspects of the gene therapy product pipeline, including setting up a commercial cGMP facility to manufacture these drugs within the IIT Kanpur Technopark facility. This unique collaboration is one of the finest examples of game changing #Industryacademia collaboration.
Chandrayaan-3 Mission:
'India🇮🇳,
I reached my destination
and you too!'
: Chandrayaan-3
Chandrayaan-3 has successfully
soft-landed on the moon 🌖!.
Congratulations, India🇮🇳!
#Chandrayaan_3#Ch3
The BSBE Department of IIT Kanpur is mighty proud of its faculty member Prof. Jayandharan G. Rao.
The investment of a corporate entity in the laboratory research of Prof. Rao marks a new era in the industry academia relationship in India.
#Hike_in_fellowship
It's time to step up and provide us the answer we deserve! We strongly urge a meeting of authorities with scholars for transparency, accountability and genuine resolutions. Together,we can foster a culture of innovation and respect.#Hike_in_fellowship@DanitaYadav
Delighted to share this great news from @IITKanpur.
We have licensed a groundbreaking #GeneTherapy technology to Reliance Life Sciences. This will lead to significant advancement in developing treatments for many hereditary eye diseases.
@reliancegroup
Course update (BSE613A-2021-22): Congratulations to team of #Ubaid@Mahimagupt20#Subhajit#ruchira on publishing their class report as a review-Role of Biomaterials in Cardiac Repair.... in ACS Biomater. Sci. Eng. @ACSBiomaterials https://t.co/vEEPeMDBuy